https://www.marketscreener.com/quote/stock/STEMLINE-THERAPEUTICS-INC-11168022/news/The-Menarini-Group-and-Stemline-Therapeutics-to-Present-Additional-Data-from-the-Phase-3-EMERALD-Stu-42451449/?utm_source=telegram&utm_medium=social&utm_campaign=share